Ex-GSK CEO to lead Alzheon's board; IBD startup raises $14.1M Series A;

@FierceBiotech: With Roche in the rearview mirror, Constellation Pharma grabs $55M round. Article | Follow @FierceBiotech

@JohnCFierce: Now we get to see if Merck KGaA can swing big and actually hit the ball. Article | Follow @JohnCFierce

> Former GlaxoSmithKline ($GSK) CEO Jean-Pierre Garnier has taken the chairman spot at Alzheon, a startup developing a treatment for Alzheimer's disease. More

> Biogen ($BIIB) is looking into leasing a 350,000-square-foot space in Cambridge, MA's biotech hotbed of Kendall Square, the Boston Business Journal reports. News

> Canadian biotech upstart Inception IBD closed a $14.1 million Series A round to support its work on treatments for inflammatory bowel disease. Versant Ventures led the round, joined by Fonds de solidarité FTQ and Inserm Transfert Initiative. Release

Medical Device News

@FierceMedDev: ICYMI yesterday: Chemotherapy cooling cap to reduce hair loss for breast cancer patients gets FDA nod. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Edwards grabs option to acquire transcather mitral valve replacement startup. Article | Follow @VarunSaxena2

@EmilyWFierce: Cornell scientists create first litter of puppies through in vitro fertilization. FierceAnimalHealth story | Follow @EmilyWFierce

> Edwards ($EW) bets on treating degenerative regurgitation via mitral repair with Harpoon investment. More

> Bloomberg: Embattled Theranos CEO continues to beat the 'transparency' drum. Story

> MicroTransponder reels in $5.5M for stroke neurostimulation device. Article

Pharma News

@FiercePharma: India's Dr. Reddy's responds to U.S. FDA warning letter. FiercePharmaAsia article | Follow @FiercePharma

@CarlyHFierce: I'm sorry, but you had 20 years to brainstorm on this, and you came up with "Dengvaxia?"  | Follow @CarlyHFierce

> FDA Commissioner to talk drug safety with top Chinese officials. More

> Sanofi ($SNY) gets first approval for long-anticipated vaccine against dengue fever. Story

> McCaskill raps 'Mr. Wu-Tang' Shkreli in Senate hearing over drug price hikes. Article

CRO News

> Icon ($ICLR) buys a trial site network with an eye on patient data. News

> WuXi ($WX) and PRA ($PRAH) break up their Chinese joint venture. More

> Charles River ($CRL) digs into Parkinson's R&D with Fox Foundation in tow. Story

> Quintiles ($Q) extends its R&D hand-holding service to biopharmas large and small. Report

> Restructured AMRI ($AMRI) cuts the ribbon on a drug discovery hub. Article

Pharma Manufacturing News

> Sucampo ($SCMP) finalizes $278M deal of R-Tech Ueno's manufacturing plant in Japan. News

> Axxess Pharma ($AXXE) has tapped SDC Nutrition for product manufacturing. Report

> FDA issues import alert on Pan Pharma, ramping up its pressure on the India drugmaker. Story

> Eli Lilly ($LLY) to manufacture human and animal drugs in separate facilities. Article

> Study: Shortfall of skilled inspectors in India hinders pharma industry. Item

Pharma Asia News

> WuXi and PRA Health amend ties in China. Item

> U.S. FDA files import alert on India's Pan Drugs. More

> China aims precision medicine plans at chronic diseases. Report

> Bangladesh again noted for dominant domestic drug manufacture. Story

> Takeda inks pact with Cour for celiac disease therapy via nanoparticles. Article

Suggested Articles

Cannabidiol might work as a powerful antibiotic against certain drug-resistant bacteria such as methicillin-resistant S. aureus.

Krystal Biotech posted data from a phase 2 study showing its topical gene therapy closed the majority of wounds in patients with a rare skin disorder.

OnKure's HDAC inhibitor overcame resistance to anti-PD-1 therapy in mouse models of B-cell lymphoma, University of Colorado researchers found.